No Data
This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
Top Premarket Decliners
William Blair Downgrades Applied Therapeutics to Market Perform
William Blair Downgrades Applied Therapeutics(APLT.US) to Hold Rating
William Blair Downgrades Applied Therapeutics (APLT) to a Hold
RBC Capital Maintains Applied Therapeutics(APLT.US) With Hold Rating, Cuts Target Price to $1.5